Le Lézard
Classified in: Health, Science and technology
Subjects: NPT, VET

MDxHealth, PsychArmor Institute, and Elizabeth Dole Foundation Launch Veteran-Focused Prostate Cancer Education Campaign


IRVINE, Calif., Nov. 15, 2018 /PRNewswire/ -- MDxHealth, PsychArmor Institute, and Elizabeth Dole Foundation have partnered to launch an online education campaign designed to improve awareness and appropriate utilization of innovative precision medicine technologies among Veterans, their caregivers, and healthcare providers. The PsychArmor Institute is a San Diego-based nonprofit working to bridge the military-civilian divide through free online education and the Elizabeth Dole Foundation works to empower, support, and honor our nation's military caregivers.

MDxHealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. (PRNewsfoto/MDxHealth)

Each year, 12,500 Veterans are diagnosed with prostate cancer, making it the most frequently diagnosed cancer among Veterans. To help address a lack of resources on this issue, the first course of the education campaign?housed in PsychArmor's School for Military Veteran Caregivers and Families?educates Veterans and their caregivers on what to expect if they are at high risk for prostate cancer. The course, entitled "Navigating the Prostate Cancer Journey: Empowering Veterans and their Caregivers with Precision Medicine," also outlines the biomarker tests they may encounter at different points throughout the diagnostic journey, and how to be a strong patient advocate.

"Precision medicine tools, such as our biomarker tests, are improving the way that doctors approach complicated and difficult-to-diagnose conditions such as prostate cancer," said Dr. Jan Groen, Chief Executive Officer of MDxHealth, a leader in the growing field of molecular diagnostics for urological oncology. "America's Veterans deserve the highest standard of care possible, and that's why we are proud that our innovative tests are available to Veterans. MDxHealth is committed to ensuring that Veterans, caregivers, and their physicians understand their options and have peace of mind throughout the diagnostic process."

Senator Elizabeth Dole, a caregiver to her Veteran husband Senator Bob Dole, explained, "Caregivers are with their Veteran at every step of the prostate cancer journey. We must ensure they're equipped with the information and tools they need to make informed decisions about their care."

"These biomarker tests are proven to reduce wait times, save money, and ? most importantly ? save lives. We're proud to partner with MDxHealth and the Elizabeth Dole Foundation to ensure that Veterans and their caregivers and healthcare providers understand the value and utility of these tests," said Marjorie Morrison, CEO and Founder of the PsychArmor Institute.

Two additional courses, which will be part of PsychArmor's School for Healthcare Providers, are being developed to educate urologists and pathologists on the value and use of precision medicine tools available to deliver faster, more accurate diagnostics to ensure patients with prostate cancer receive appropriate care at the appropriate time.

Prostate cancer is extremely difficult to diagnose ? it is symptomless in its early stages, and biopsies often miss detecting cancer. Biomarker tests use genetics and genomics to improve clinicians' ability to detect the disease earlier and determine the right treatment path. Currently, there are five prostate cancer biomarker tests available on the Federal Supply Schedule (FSS) for use by physicians who serve Veterans, including SelectMDx and ConfirmMDx.

About MDxHealth®
MDxHealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary genetic, epigenetic and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The Company's European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarter and laboratory operations based in Irvine, California. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.

About PsychArmor Institute
PsychArmor Institute is the only non-profit organization in the country exclusively dedicated to providing FREE online educational courses to all who work with, live with, or care for members of the military community. Its online library of more than 108 short, self-paced course modules is available 24/7. All PsychArmor courses are evidence-based, clinically informed, and developed by national recognized subject matter experts. For more information about PsychArmor, please visit www.psycharmor.org. You can also follow PsychArmor on Twitter, Facebook, LinkedIn, and Instagram.

About Elizabeth Dole Foundation
The Elizabeth Dole Foundation is the preeminent organization empowering, supporting, and honoring our nation's 5.5 million military caregivers ? the spouses, parents, family members, and friends who care for America's wounded, ill or injured veterans at home. Founded by Senator Elizabeth Dole in 2012, the Foundation adopts a comprehensive approach in its support and advocacy, working with leaders in the public, private, nonprofit, and faith communities to recognize military caregivers' service and promote their well-being. Learn more about the Elizabeth Dole Foundation at www.elizabethdolefoundation.org.

For more information:
Casey Dillon
+1 703-479-3644
[email protected]

 

PsychArmor Institute is a national nonprofit that provides free online education and support to all Americans who work with, live with or care for Military Service Members, Veterans and their families.

The Elizabeth Dole Foundation seeks to empower military caregivers by strengthening services through research, innovation, and collaboration.

SOURCE MDxHealth


These press releases may also interest you

at 06:50
Merck , known as MSD outside of the United States and Canada, today announced that the European Commission (EC) has approved KEYTRUDA, Merck's anti-PD-1 therapy, in combination with platinum-containing chemotherapy as neoadjuvant treatment, then...

at 06:45
RentRedi, an award-winning property management software that simplifies the renting process for both landlords and renters, has expanded its on-time rent reporting to all three major credit bureaus: Equifax, Experian, and TransUnion. The ability to...

at 06:40
Monport, a frontrunner in laser technology innovation, proudly presents its latest marvel: The Monport GPro MOPA Fiber Laser Engraver. This cutting-edge machine is poised to redefine precision marking with its unparalleled capabilities and advanced...

at 06:34
Trip.com Group has announced record bookings in Abu Dhabi, exceeding 57,000 room nights over the past 12 months. Following a strategic partnership signed at the Arabian Travel Market last year, Trip.com Group's comprehensive portfolio of travel...

at 06:31
Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annual...

at 06:30
Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular...



News published on and distributed by: